Caesarean Wound Dressing Removal Study (Cesarean)

January 15, 2025 updated by: Zahar Azuar Zakaria, Hospital Kemaman

A Randomised Controlled Trial on the Timing of Wound Dressing Removal After Emergency Caesarean Delivery

An open labelled randomised trial on the timing of wound dressing removal for emergency caesarean delivery in labour.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The trial is unblinded randomised trial on surgical wound dressing at 24 versus 48 hours after the emergency caesarean delivery in labour.

The primary outcome is the prevalence of wound complications (hematoma, seroma, infection/ dehiscence) The secondary objectives are the maximum pain after the surgery (in ward) and the timing of the patient's first bath after the surgery

Study Type

Interventional

Enrollment (Actual)

294

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Malaysia
    • Terengganu
      • Kampong Kemaman, Terengganu, Malaysia, 24000
        • Hospital Kemaman

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Age 18-50
  2. Lower segment caesarean delivery
  3. Primary or repeat caesarean delivery
  4. Caesarean section in active phase of labour.
  5. Regional anaesthesia

Exclusion Criteria:

  1. Upper segment or classical caesarean delivery
  2. Massive postpartum haemorrhage > 1.5 litre
  3. Pre-delivery chorioamnionitis
  4. Skin closure using interrupted suture
  5. Acquired or congenital coagulation disorder
  6. Associated medical or obstetric condition requiring prolonged hospital stay after delivery such as severe pre-eclampsia, uncontrolled diabetes mellitus, cardiac disease, systemic infection.
  7. Inability to give consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Dressing removal at 24 hours
The wound dressing will be removed 24 hours after emergency cesarean delivery
Procedure: Cesarean wound dressing removal
The cesarean wound dressing is to be removed and the surgical wound exposed
Placebo Comparator: Dressing removal at 48 hours
The wound dressing will be removed 48 hours after emergency cesarean delivery
Procedure: Cesarean wound dressing removal
The cesarean wound dressing is to be removed and the surgical wound exposed

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cesarean wound complication
Time Frame: 30 days
Hematoma, seroma, wound infection, wound dehiscence
30 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain control
Time Frame: 48 hours
Perceived pain after caesarean according to Visual Analogue Scale (0/10 = no pain; 10/10 = worst pain)
48 hours
Self hygiene
Time Frame: 48 hours
Timing of first bath after surgery
48 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hospital Kemaman

Investigators

  • Principal Investigator: Zahar A Zakaria, MD, Hospital Kemaman

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2022

Primary Completion (Actual)

September 25, 2024

Study Completion (Actual)

December 31, 2024

Study Registration Dates

First Submitted

July 4, 2022

First Submitted That Met QC Criteria

July 12, 2022

First Posted (Actual)

July 14, 2022

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 15, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NMRR ID-22-00321-NZM

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgical Wound

Clinical Trials on Cesarean wound dressing removal

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe